Ra Capital Management, L.P. Wave Life Sciences Ltd. Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
A detailed history of Ra Capital Management, L.P. transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Ra Capital Management, L.P. holds 18,202,009 shares of WVE stock, worth $259 Million. This represents 2.08% of its overall portfolio holdings.
Number of Shares
18,202,009
Previous 18,202,009
-0.0%
Holding current value
$259 Million
Previous $90.8 Million
64.33%
% of portfolio
2.08%
Previous 1.37%
Shares
6 transactions
Others Institutions Holding WVE
# of Institutions
164Shares Held
117MCall Options Held
148KPut Options Held
109K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx10MShares$143 Million1.71% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.7MShares$138 Million0.15% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$95.8 Million0.0% of portfolio
-
M28 Capital Management LP Stamford, CT6.16MShares$87.6 Million48.05% of portfolio
-
Driehaus Capital Management LLC Chicago, IL5.86MShares$83.3 Million0.47% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $1.23B
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...